Corvus Pharmaceuticals CRVS SEC Filings

NASDAQ CRVS
$14.51 -0.14 (-0.96%)
As of: Sep 4, 2026 · 2:26 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Corvus Pharmaceuticals, Inc. (CRVS) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index